Klin Monbl Augenheilkd
DOI: 10.1055/a-2200-5062
Kasuistik

Isolated Conjunctival Lymphaticovenous Malformation Presenting as Persistent Conjunctival Chemosis

Eine persistierende konjunktivale Chemose erwies sich als isolierte konjunktivale lymphatisch-venöse Malformation
Victor Brantl
Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
,
Elisabeth Messmer
Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
,
Andreas Ohlmann
Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
,
Siegfried Priglinger
Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
,
Anna Schuh
Department of Ophthalmology, LMU University Hospital, LMU Munich, Germany
› Author Affiliations

Introduction

Vascular lesions of the conjunctiva are a group of rare conditions that involve abnormal growth or development of blood vessels or lymphatics in the conjunctiva [1], [2], [3], [4], [5]. They may present as dilated, tortuous, or malformed vessels, which can cause redness, swelling, and bleeding in the affected area [1], [2], [3], [4], [5]. They can be broadly classified into two main categories: vascular tumors such as hemangioma, and vascular malformations such as hamartoma or lymphaticovenous malformations (LVM), formerly known as lymphangiomas [1], [2], [3], [4], [5], [6]. Vascular tumors are characterized by the presence of rapidly growing, well-defined masses of blood vessels, while vascular malformations are typically present at birth and consist of abnormally formed blood vessels that do not proliferate like tumors [6]. In addition to these benign tumors and malformations, Kaposisʼs sarcoma is a rare malignant tumor [2]. All these lesions can affect one or both eyes, and may cause symptoms such as blurred vision, foreign body sensation, redness, epiphora and bleeding. Treatment strategies depend on the etiology, size and location of the lesion as well as the patientʼs symptoms, and may include observation, surgical excision, laser- and cryotherapy, or the injection of therapeutic agents, etc. [1] – [9]. We describe a patient with an isolated conjunctival LVM, who presented with cystic subconjunctival hemorrhage to our emergency department.



Publication History

Received: 15 June 2023

Accepted: 20 October 2023

Accepted Manuscript online:
27 October 2023

Article published online:
19 January 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Shields JA, Mashayekhi A, Kligman BE. et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology 2011; 118: 1747-1753 DOI: 10.1016/j.ophtha.2011.04.034.
  • 2 Murray N, McCluskey P, Wakefield D. et al. Isolated bulbar conjunctival Kaposiʼs sarcoma. Aust N Z J Ophthalmol 1994; 22: 81-82 DOI: 10.1111/j.1442-9071.1994.tb01702.x.
  • 3 Rootman J, Hay E, Graeb D. et al. Orbital-adnexal lymphangiomas. A spectrum of hemodynamically isolated vascular hamartomas. Ophthalmology 1986; 93: 1558-1570
  • 4 Nassiri N, Rootman J, Rootman DB. et al. Orbital lymphaticovenous malformations: Current and future treatments. Surv Ophthalmol 2015; 60: 383-405 DOI: 10.1016/j.survophthal.2015.03.001.
  • 5 Jones IS. Lymphangiomas of the ocular adnexa. An analysis of sixty-two cases. Am J Ophthalmol 1961; 51: 481-509 DOI: 10.1016/0002-9394(61)92094-3.
  • 6 Jakobiec FA, Werdich XQ, Chodosh J. et al. An analysis of conjunctival and periocular venous malformations: clinicopathologic and immunohistochemical features with a comparison of racemose and cirsoid lesions. Surv Ophthalmol 2014; 59: 236-244 DOI: 10.1016/j.survophthal.2013.06.003.
  • 7 Behrendt S, Bernsmeier H, Randzio G. Fractionated beta-irradiation of a conjunctival lymphangioma. Ophthalmologica 1991; 203: 161-163 DOI: 10.1159/000310244.
  • 8 Bansal S, Das S. Intralesional bleomycin: A treatment modality for conjunctival lymphangioma. Oman J Ophthalmol 2020; 13: 43-45 DOI: 10.4103/ojo.OJO_44_2019.
  • 9 Abdelaziz O, Hassan F, Elessawy K. et al. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children. Cardiovasc Intervent Radiol 2019; 42: 433-440 DOI: 10.1007/s00270-018-2128-4.
  • 10 Wiegand S, Eivazi B, Barth PJ. et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453: 1-8 DOI: 10.1007/s00428-008-0611-z.
  • 11 Cohen jr. MM. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A 2006; 140: 2013-2038 DOI: 10.1002/ajmg.a.31333.
  • 12 Harris GJ. Orbital vascular malformations: a consensus statement on terminology and its clinical implications. Orbital Society. Am J Ophthalmol 1999; 127: 453-455 DOI: 10.1016/s0002-9394(99)00048-3.
  • 13 Wassef M, Blei F, Adams D. ISSVA Board and Scientific Committee. Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics 2015; 136: e203-e214 DOI: 10.1542/peds.2014-3673.
  • 14 Duke-Elder S. Diseases of the Outer Eye. In: Duke-Elder S. ed. System of Ophthalmology, Vol. 8, Part 1. St. Louis, Mo, USA: Mosby; 1965